Figure 1: Patent sequences mapped on the human genome (GRCh37 at http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/index.shtml).

(a) Mapping was based on various similarity and query length coverage rates (90% 50%, 98% 95%, and 100% 100%). Unique patent sequences refer to sequences with only unique mapping locus. Although the majority of nonredundant sequences were declared human in the patent documents, around 20% were unspecified or nonhuman. (b) The internal chart shows only mapped sequences that are referenced in the granted claims (1% of the data); redundant sequence counts (R), nonredundant sequence counts (NR) and their corresponding patent grants counts. (c) Homology-based human transcriptome and proteome analysis based on two filters of E-value and percentage of minimum hit coverage.